CHK1 Inhibitor Blocks Phosphorylation of FAM122A and Promotes Replication Stress Article Swipe
Feng Li
,
David Kozono
,
Peter Deraska
,
Timothy B. Branigan
,
Connor E. Dunn
,
Xiao-Feng Zheng
,
Kalindi Parmar
,
Huy Nguyen
,
James A. DeCaprio
,
Geoffrey I. Shapiro
,
Dipanjan Chowdhury
,
Alan D. D’Andrea
·
YOU?
·
· 2020
· Open Access
·
· DOI: https://doi.org/10.1016/j.molcel.2020.10.008
YOU?
·
· 2020
· Open Access
·
· DOI: https://doi.org/10.1016/j.molcel.2020.10.008
Related Topics
Concepts
Wee1
Biology
Protein phosphatase 2
CHEK1
Phosphatase
Kinase
Cancer research
Phosphorylation
Cell cycle
DNA damage
Cell biology
Cancer
Cell cycle checkpoint
Cyclin-dependent kinase 1
Genetics
DNA
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1016/j.molcel.2020.10.008
- OA Status
- green
- Cited By
- 51
- References
- 50
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W3096771938
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W3096771938Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1016/j.molcel.2020.10.008Digital Object Identifier
- Title
-
CHK1 Inhibitor Blocks Phosphorylation of FAM122A and Promotes Replication StressWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2020Year of publication
- Publication date
-
2020-10-26Full publication date if available
- Authors
-
Feng Li, David Kozono, Peter Deraska, Timothy B. Branigan, Connor E. Dunn, Xiao-Feng Zheng, Kalindi Parmar, Huy Nguyen, James A. DeCaprio, Geoffrey I. Shapiro, Dipanjan Chowdhury, Alan D. D’AndreaList of authors in order
- Landing page
-
https://doi.org/10.1016/j.molcel.2020.10.008Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
greenOpen access status per OpenAlex
- OA URL
-
https://www.ncbi.nlm.nih.gov/pmc/articles/7761918Direct OA link when available
- Concepts
-
Wee1, Biology, Protein phosphatase 2, CHEK1, Phosphatase, Kinase, Cancer research, Phosphorylation, Cell cycle, DNA damage, Cell biology, Cancer, Cell cycle checkpoint, Cyclin-dependent kinase 1, Genetics, DNATop concepts (fields/topics) attached by OpenAlex
- Cited by
-
51Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 8, 2024: 8, 2023: 13, 2022: 11, 2021: 10Per-year citation counts (last 5 years)
- References (count)
-
50Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W3096771938 |
|---|---|
| doi | https://doi.org/10.1016/j.molcel.2020.10.008 |
| ids.doi | https://doi.org/10.1016/j.molcel.2020.10.008 |
| ids.mag | 3096771938 |
| ids.openalex | https://openalex.org/W3096771938 |
| fwci | 3.41344406 |
| type | article |
| title | CHK1 Inhibitor Blocks Phosphorylation of FAM122A and Promotes Replication Stress |
| biblio.issue | 3 |
| biblio.volume | 80 |
| biblio.last_page | 422.e6 |
| biblio.first_page | 410 |
| grants[0].funder | https://openalex.org/F4320306078 |
| grants[0].award_id | |
| grants[0].funder_display_name | U.S. Department of Defense |
| grants[1].funder | https://openalex.org/F4320306260 |
| grants[1].award_id | |
| grants[1].funder_display_name | Breast Cancer Research Foundation |
| grants[2].funder | https://openalex.org/F4320306947 |
| grants[2].award_id | |
| grants[2].funder_display_name | Fanconi Anemia Research Fund |
| grants[3].funder | https://openalex.org/F4320307758 |
| grants[3].award_id | |
| grants[3].funder_display_name | Eli Lilly and Company |
| grants[4].funder | https://openalex.org/F4320332161 |
| grants[4].award_id | |
| grants[4].funder_display_name | National Institutes of Health |
| grants[5].funder | https://openalex.org/F4320332505 |
| grants[5].award_id | |
| grants[5].funder_display_name | U.S. Public Health Service |
| topics[0].id | https://openalex.org/T11041 |
| topics[0].field.id | https://openalex.org/fields/13 |
| topics[0].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[0].score | 0.9998000264167786 |
| topics[0].domain.id | https://openalex.org/domains/1 |
| topics[0].domain.display_name | Life Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/1312 |
| topics[0].subfield.display_name | Molecular Biology |
| topics[0].display_name | Ubiquitin and proteasome pathways |
| topics[1].id | https://openalex.org/T10123 |
| topics[1].field.id | https://openalex.org/fields/13 |
| topics[1].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[1].score | 0.9987000226974487 |
| topics[1].domain.id | https://openalex.org/domains/1 |
| topics[1].domain.display_name | Life Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/1312 |
| topics[1].subfield.display_name | Molecular Biology |
| topics[1].display_name | DNA Repair Mechanisms |
| topics[2].id | https://openalex.org/T11772 |
| topics[2].field.id | https://openalex.org/fields/13 |
| topics[2].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[2].score | 0.9968000054359436 |
| topics[2].domain.id | https://openalex.org/domains/1 |
| topics[2].domain.display_name | Life Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/1311 |
| topics[2].subfield.display_name | Genetics |
| topics[2].display_name | Genetics and Neurodevelopmental Disorders |
| funders[0].id | https://openalex.org/F4320306078 |
| funders[0].ror | https://ror.org/0447fe631 |
| funders[0].display_name | U.S. Department of Defense |
| funders[1].id | https://openalex.org/F4320306260 |
| funders[1].ror | https://ror.org/0348ff195 |
| funders[1].display_name | Breast Cancer Research Foundation |
| funders[2].id | https://openalex.org/F4320306947 |
| funders[2].ror | https://ror.org/04w07g537 |
| funders[2].display_name | Fanconi Anemia Research Fund |
| funders[3].id | https://openalex.org/F4320307758 |
| funders[3].ror | https://ror.org/01qat3289 |
| funders[3].display_name | Eli Lilly and Company |
| funders[4].id | https://openalex.org/F4320332161 |
| funders[4].ror | https://ror.org/01cwqze88 |
| funders[4].display_name | National Institutes of Health |
| funders[5].id | https://openalex.org/F4320332505 |
| funders[5].ror | https://ror.org/05xf94514 |
| funders[5].display_name | U.S. Public Health Service |
| is_xpac | False |
| apc_list.value | 9080 |
| apc_list.currency | USD |
| apc_list.value_usd | 9080 |
| apc_paid | |
| concepts[0].id | https://openalex.org/C2781252693 |
| concepts[0].level | 5 |
| concepts[0].score | 0.9150093793869019 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q7979264 |
| concepts[0].display_name | Wee1 |
| concepts[1].id | https://openalex.org/C86803240 |
| concepts[1].level | 0 |
| concepts[1].score | 0.8116214871406555 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[1].display_name | Biology |
| concepts[2].id | https://openalex.org/C389152 |
| concepts[2].level | 4 |
| concepts[2].score | 0.7100745439529419 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q6593007 |
| concepts[2].display_name | Protein phosphatase 2 |
| concepts[3].id | https://openalex.org/C50001416 |
| concepts[3].level | 5 |
| concepts[3].score | 0.6614269018173218 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q17861750 |
| concepts[3].display_name | CHEK1 |
| concepts[4].id | https://openalex.org/C178666793 |
| concepts[4].level | 3 |
| concepts[4].score | 0.6114723682403564 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q422476 |
| concepts[4].display_name | Phosphatase |
| concepts[5].id | https://openalex.org/C184235292 |
| concepts[5].level | 2 |
| concepts[5].score | 0.5735575556755066 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q421851 |
| concepts[5].display_name | Kinase |
| concepts[6].id | https://openalex.org/C502942594 |
| concepts[6].level | 1 |
| concepts[6].score | 0.48972252011299133 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q3421914 |
| concepts[6].display_name | Cancer research |
| concepts[7].id | https://openalex.org/C11960822 |
| concepts[7].level | 2 |
| concepts[7].score | 0.47625017166137695 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q242736 |
| concepts[7].display_name | Phosphorylation |
| concepts[8].id | https://openalex.org/C29537977 |
| concepts[8].level | 3 |
| concepts[8].score | 0.4723927676677704 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q188941 |
| concepts[8].display_name | Cell cycle |
| concepts[9].id | https://openalex.org/C143425029 |
| concepts[9].level | 3 |
| concepts[9].score | 0.4568648040294647 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q5205747 |
| concepts[9].display_name | DNA damage |
| concepts[10].id | https://openalex.org/C95444343 |
| concepts[10].level | 1 |
| concepts[10].score | 0.4563503861427307 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q7141 |
| concepts[10].display_name | Cell biology |
| concepts[11].id | https://openalex.org/C121608353 |
| concepts[11].level | 2 |
| concepts[11].score | 0.33264100551605225 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q12078 |
| concepts[11].display_name | Cancer |
| concepts[12].id | https://openalex.org/C105696609 |
| concepts[12].level | 4 |
| concepts[12].score | 0.3307882249355316 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q1068809 |
| concepts[12].display_name | Cell cycle checkpoint |
| concepts[13].id | https://openalex.org/C120504264 |
| concepts[13].level | 4 |
| concepts[13].score | 0.23486772179603577 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q1147372 |
| concepts[13].display_name | Cyclin-dependent kinase 1 |
| concepts[14].id | https://openalex.org/C54355233 |
| concepts[14].level | 1 |
| concepts[14].score | 0.1649865210056305 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q7162 |
| concepts[14].display_name | Genetics |
| concepts[15].id | https://openalex.org/C552990157 |
| concepts[15].level | 2 |
| concepts[15].score | 0.10574054718017578 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q7430 |
| concepts[15].display_name | DNA |
| keywords[0].id | https://openalex.org/keywords/wee1 |
| keywords[0].score | 0.9150093793869019 |
| keywords[0].display_name | Wee1 |
| keywords[1].id | https://openalex.org/keywords/biology |
| keywords[1].score | 0.8116214871406555 |
| keywords[1].display_name | Biology |
| keywords[2].id | https://openalex.org/keywords/protein-phosphatase-2 |
| keywords[2].score | 0.7100745439529419 |
| keywords[2].display_name | Protein phosphatase 2 |
| keywords[3].id | https://openalex.org/keywords/chek1 |
| keywords[3].score | 0.6614269018173218 |
| keywords[3].display_name | CHEK1 |
| keywords[4].id | https://openalex.org/keywords/phosphatase |
| keywords[4].score | 0.6114723682403564 |
| keywords[4].display_name | Phosphatase |
| keywords[5].id | https://openalex.org/keywords/kinase |
| keywords[5].score | 0.5735575556755066 |
| keywords[5].display_name | Kinase |
| keywords[6].id | https://openalex.org/keywords/cancer-research |
| keywords[6].score | 0.48972252011299133 |
| keywords[6].display_name | Cancer research |
| keywords[7].id | https://openalex.org/keywords/phosphorylation |
| keywords[7].score | 0.47625017166137695 |
| keywords[7].display_name | Phosphorylation |
| keywords[8].id | https://openalex.org/keywords/cell-cycle |
| keywords[8].score | 0.4723927676677704 |
| keywords[8].display_name | Cell cycle |
| keywords[9].id | https://openalex.org/keywords/dna-damage |
| keywords[9].score | 0.4568648040294647 |
| keywords[9].display_name | DNA damage |
| keywords[10].id | https://openalex.org/keywords/cell-biology |
| keywords[10].score | 0.4563503861427307 |
| keywords[10].display_name | Cell biology |
| keywords[11].id | https://openalex.org/keywords/cancer |
| keywords[11].score | 0.33264100551605225 |
| keywords[11].display_name | Cancer |
| keywords[12].id | https://openalex.org/keywords/cell-cycle-checkpoint |
| keywords[12].score | 0.3307882249355316 |
| keywords[12].display_name | Cell cycle checkpoint |
| keywords[13].id | https://openalex.org/keywords/cyclin-dependent-kinase-1 |
| keywords[13].score | 0.23486772179603577 |
| keywords[13].display_name | Cyclin-dependent kinase 1 |
| keywords[14].id | https://openalex.org/keywords/genetics |
| keywords[14].score | 0.1649865210056305 |
| keywords[14].display_name | Genetics |
| keywords[15].id | https://openalex.org/keywords/dna |
| keywords[15].score | 0.10574054718017578 |
| keywords[15].display_name | DNA |
| language | en |
| locations[0].id | doi:10.1016/j.molcel.2020.10.008 |
| locations[0].is_oa | False |
| locations[0].source.id | https://openalex.org/S156208185 |
| locations[0].source.issn | 1097-2765, 1097-4164 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 1097-2765 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Molecular Cell |
| locations[0].source.host_organization | https://openalex.org/P4310320990 |
| locations[0].source.host_organization_name | Elsevier BV |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320990 |
| locations[0].license | |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Molecular Cell |
| locations[0].landing_page_url | https://doi.org/10.1016/j.molcel.2020.10.008 |
| locations[1].id | pmh:oai:pubmedcentral.nih.gov:7761918 |
| locations[1].is_oa | True |
| locations[1].source.id | https://openalex.org/S2764455111 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed Central |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | submittedVersion |
| locations[1].raw_type | Text |
| locations[1].license_id | |
| locations[1].is_accepted | False |
| locations[1].is_published | False |
| locations[1].raw_source_name | Mol Cell |
| locations[1].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/7761918 |
| locations[2].id | pmh:oai:europepmc.org:7455070 |
| locations[2].is_oa | False |
| locations[2].source.id | https://openalex.org/S4306400806 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | Europe PMC (PubMed Central) |
| locations[2].source.host_organization | https://openalex.org/I1303153112 |
| locations[2].source.host_organization_name | European Bioinformatics Institute |
| locations[2].source.host_organization_lineage | https://openalex.org/I1303153112 |
| locations[2].license | |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | |
| locations[2].landing_page_url | http://europepmc.org/pmc/articles/PMC7761918 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5100653921 |
| authorships[0].author.orcid | https://orcid.org/0000-0003-4703-5537 |
| authorships[0].author.display_name | Feng Li |
| authorships[0].countries | US |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I4210117453 |
| authorships[0].affiliations[0].raw_affiliation_string | Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA |
| authorships[0].institutions[0].id | https://openalex.org/I4210117453 |
| authorships[0].institutions[0].ror | https://ror.org/02jzgtq86 |
| authorships[0].institutions[0].type | facility |
| authorships[0].institutions[0].lineage | https://openalex.org/I4210117453 |
| authorships[0].institutions[0].country_code | US |
| authorships[0].institutions[0].display_name | Dana-Farber Cancer Institute |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Feng Li |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA |
| authorships[1].author.id | https://openalex.org/A5075890039 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-8916-396X |
| authorships[1].author.display_name | David Kozono |
| authorships[1].countries | US |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I4210117453 |
| authorships[1].affiliations[0].raw_affiliation_string | Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA |
| authorships[1].institutions[0].id | https://openalex.org/I4210117453 |
| authorships[1].institutions[0].ror | https://ror.org/02jzgtq86 |
| authorships[1].institutions[0].type | facility |
| authorships[1].institutions[0].lineage | https://openalex.org/I4210117453 |
| authorships[1].institutions[0].country_code | US |
| authorships[1].institutions[0].display_name | Dana-Farber Cancer Institute |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | David Kozono |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA |
| authorships[2].author.id | https://openalex.org/A5019144080 |
| authorships[2].author.orcid | https://orcid.org/0000-0001-7689-2568 |
| authorships[2].author.display_name | Peter Deraska |
| authorships[2].countries | US |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I4210117453 |
| authorships[2].affiliations[0].raw_affiliation_string | Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA |
| authorships[2].affiliations[1].institution_ids | https://openalex.org/I4210117453 |
| authorships[2].affiliations[1].raw_affiliation_string | Center for DNA Damage and Repair, Dana-Farber Cancer Institute, Boston, MA 02215, USA |
| authorships[2].institutions[0].id | https://openalex.org/I4210117453 |
| authorships[2].institutions[0].ror | https://ror.org/02jzgtq86 |
| authorships[2].institutions[0].type | facility |
| authorships[2].institutions[0].lineage | https://openalex.org/I4210117453 |
| authorships[2].institutions[0].country_code | US |
| authorships[2].institutions[0].display_name | Dana-Farber Cancer Institute |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Peter Deraska |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Center for DNA Damage and Repair, Dana-Farber Cancer Institute, Boston, MA 02215, USA, Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA |
| authorships[3].author.id | https://openalex.org/A5031193500 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-8641-5332 |
| authorships[3].author.display_name | Timothy B. Branigan |
| authorships[3].countries | US |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I4210117453 |
| authorships[3].affiliations[0].raw_affiliation_string | Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 01115 |
| authorships[3].institutions[0].id | https://openalex.org/I4210117453 |
| authorships[3].institutions[0].ror | https://ror.org/02jzgtq86 |
| authorships[3].institutions[0].type | facility |
| authorships[3].institutions[0].lineage | https://openalex.org/I4210117453 |
| authorships[3].institutions[0].country_code | US |
| authorships[3].institutions[0].display_name | Dana-Farber Cancer Institute |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Timothy Branigan |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 01115 |
| authorships[4].author.id | https://openalex.org/A5002170796 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-2057-8673 |
| authorships[4].author.display_name | Connor E. Dunn |
| authorships[4].countries | US |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I4210117453 |
| authorships[4].affiliations[0].raw_affiliation_string | Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA |
| authorships[4].affiliations[1].institution_ids | https://openalex.org/I4210117453 |
| authorships[4].affiliations[1].raw_affiliation_string | Center for DNA Damage and Repair, Dana-Farber Cancer Institute, Boston, MA 02215, USA |
| authorships[4].institutions[0].id | https://openalex.org/I4210117453 |
| authorships[4].institutions[0].ror | https://ror.org/02jzgtq86 |
| authorships[4].institutions[0].type | facility |
| authorships[4].institutions[0].lineage | https://openalex.org/I4210117453 |
| authorships[4].institutions[0].country_code | US |
| authorships[4].institutions[0].display_name | Dana-Farber Cancer Institute |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Connor Dunn |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Center for DNA Damage and Repair, Dana-Farber Cancer Institute, Boston, MA 02215, USA, Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA |
| authorships[5].author.id | https://openalex.org/A5033495224 |
| authorships[5].author.orcid | https://orcid.org/0000-0001-8769-4604 |
| authorships[5].author.display_name | Xiao-Feng Zheng |
| authorships[5].countries | US |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I4210117453 |
| authorships[5].affiliations[0].raw_affiliation_string | Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA |
| authorships[5].institutions[0].id | https://openalex.org/I4210117453 |
| authorships[5].institutions[0].ror | https://ror.org/02jzgtq86 |
| authorships[5].institutions[0].type | facility |
| authorships[5].institutions[0].lineage | https://openalex.org/I4210117453 |
| authorships[5].institutions[0].country_code | US |
| authorships[5].institutions[0].display_name | Dana-Farber Cancer Institute |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Xiao-Feng Zheng |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA |
| authorships[6].author.id | https://openalex.org/A5043442872 |
| authorships[6].author.orcid | https://orcid.org/0000-0002-9522-1716 |
| authorships[6].author.display_name | Kalindi Parmar |
| authorships[6].countries | US |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I4210117453 |
| authorships[6].affiliations[0].raw_affiliation_string | Center for DNA Damage and Repair, Dana-Farber Cancer Institute, Boston, MA 02215, USA |
| authorships[6].affiliations[1].institution_ids | https://openalex.org/I4210117453 |
| authorships[6].affiliations[1].raw_affiliation_string | Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA |
| authorships[6].institutions[0].id | https://openalex.org/I4210117453 |
| authorships[6].institutions[0].ror | https://ror.org/02jzgtq86 |
| authorships[6].institutions[0].type | facility |
| authorships[6].institutions[0].lineage | https://openalex.org/I4210117453 |
| authorships[6].institutions[0].country_code | US |
| authorships[6].institutions[0].display_name | Dana-Farber Cancer Institute |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Kalindi Parmar |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Center for DNA Damage and Repair, Dana-Farber Cancer Institute, Boston, MA 02215, USA, Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA |
| authorships[7].author.id | https://openalex.org/A5005950027 |
| authorships[7].author.orcid | https://orcid.org/0000-0002-4424-1047 |
| authorships[7].author.display_name | Huy Nguyen |
| authorships[7].countries | US |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I4210117453 |
| authorships[7].affiliations[0].raw_affiliation_string | Center for DNA Damage and Repair, Dana-Farber Cancer Institute, Boston, MA 02215, USA |
| authorships[7].affiliations[1].institution_ids | https://openalex.org/I4210117453 |
| authorships[7].affiliations[1].raw_affiliation_string | Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA |
| authorships[7].institutions[0].id | https://openalex.org/I4210117453 |
| authorships[7].institutions[0].ror | https://ror.org/02jzgtq86 |
| authorships[7].institutions[0].type | facility |
| authorships[7].institutions[0].lineage | https://openalex.org/I4210117453 |
| authorships[7].institutions[0].country_code | US |
| authorships[7].institutions[0].display_name | Dana-Farber Cancer Institute |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Huy Nguyen |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Center for DNA Damage and Repair, Dana-Farber Cancer Institute, Boston, MA 02215, USA, Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA |
| authorships[8].author.id | https://openalex.org/A5081560191 |
| authorships[8].author.orcid | https://orcid.org/0000-0002-0896-167X |
| authorships[8].author.display_name | James A. DeCaprio |
| authorships[8].countries | US |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I4210117453 |
| authorships[8].affiliations[0].raw_affiliation_string | Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 01115 |
| authorships[8].institutions[0].id | https://openalex.org/I4210117453 |
| authorships[8].institutions[0].ror | https://ror.org/02jzgtq86 |
| authorships[8].institutions[0].type | facility |
| authorships[8].institutions[0].lineage | https://openalex.org/I4210117453 |
| authorships[8].institutions[0].country_code | US |
| authorships[8].institutions[0].display_name | Dana-Farber Cancer Institute |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | James DeCaprio |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 01115 |
| authorships[9].author.id | https://openalex.org/A5045419282 |
| authorships[9].author.orcid | https://orcid.org/0000-0002-3331-4095 |
| authorships[9].author.display_name | Geoffrey I. Shapiro |
| authorships[9].countries | US |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I4210117453 |
| authorships[9].affiliations[0].raw_affiliation_string | Early Drug Development Center, Dana-Farber Cancer Institute, Boston, MA 02215 |
| authorships[9].affiliations[1].institution_ids | https://openalex.org/I4210117453 |
| authorships[9].affiliations[1].raw_affiliation_string | Center for DNA Damage and Repair, Dana-Farber Cancer Institute, Boston, MA 02215, USA |
| authorships[9].affiliations[2].institution_ids | https://openalex.org/I4210117453 |
| authorships[9].affiliations[2].raw_affiliation_string | Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 01115 |
| authorships[9].institutions[0].id | https://openalex.org/I4210117453 |
| authorships[9].institutions[0].ror | https://ror.org/02jzgtq86 |
| authorships[9].institutions[0].type | facility |
| authorships[9].institutions[0].lineage | https://openalex.org/I4210117453 |
| authorships[9].institutions[0].country_code | US |
| authorships[9].institutions[0].display_name | Dana-Farber Cancer Institute |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Geoffrey I. Shapiro |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | Center for DNA Damage and Repair, Dana-Farber Cancer Institute, Boston, MA 02215, USA, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 01115, Early Drug Development Center, Dana-Farber Cancer Institute, Boston, MA 02215 |
| authorships[10].author.id | https://openalex.org/A5004787236 |
| authorships[10].author.orcid | https://orcid.org/0000-0001-5645-3752 |
| authorships[10].author.display_name | Dipanjan Chowdhury |
| authorships[10].countries | US |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I4210117453 |
| authorships[10].affiliations[0].raw_affiliation_string | Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA |
| authorships[10].institutions[0].id | https://openalex.org/I4210117453 |
| authorships[10].institutions[0].ror | https://ror.org/02jzgtq86 |
| authorships[10].institutions[0].type | facility |
| authorships[10].institutions[0].lineage | https://openalex.org/I4210117453 |
| authorships[10].institutions[0].country_code | US |
| authorships[10].institutions[0].display_name | Dana-Farber Cancer Institute |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Dipanjan Chowdhury |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA |
| authorships[11].author.id | https://openalex.org/A5044648110 |
| authorships[11].author.orcid | https://orcid.org/0000-0001-6168-6294 |
| authorships[11].author.display_name | Alan D. D’Andrea |
| authorships[11].countries | US |
| authorships[11].affiliations[0].institution_ids | https://openalex.org/I4210117453 |
| authorships[11].affiliations[0].raw_affiliation_string | Center for DNA Damage and Repair, Dana-Farber Cancer Institute, Boston, MA 02215, USA |
| authorships[11].affiliations[1].institution_ids | https://openalex.org/I4210117453 |
| authorships[11].affiliations[1].raw_affiliation_string | Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA |
| authorships[11].institutions[0].id | https://openalex.org/I4210117453 |
| authorships[11].institutions[0].ror | https://ror.org/02jzgtq86 |
| authorships[11].institutions[0].type | facility |
| authorships[11].institutions[0].lineage | https://openalex.org/I4210117453 |
| authorships[11].institutions[0].country_code | US |
| authorships[11].institutions[0].display_name | Dana-Farber Cancer Institute |
| authorships[11].author_position | last |
| authorships[11].raw_author_name | Alan D. D’Andrea |
| authorships[11].is_corresponding | True |
| authorships[11].raw_affiliation_strings | Center for DNA Damage and Repair, Dana-Farber Cancer Institute, Boston, MA 02215, USA, Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://www.ncbi.nlm.nih.gov/pmc/articles/7761918 |
| open_access.oa_status | green |
| open_access.any_repository_has_fulltext | False |
| created_date | 2020-11-09T00:00:00 |
| display_name | CHK1 Inhibitor Blocks Phosphorylation of FAM122A and Promotes Replication Stress |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T11041 |
| primary_topic.field.id | https://openalex.org/fields/13 |
| primary_topic.field.display_name | Biochemistry, Genetics and Molecular Biology |
| primary_topic.score | 0.9998000264167786 |
| primary_topic.domain.id | https://openalex.org/domains/1 |
| primary_topic.domain.display_name | Life Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/1312 |
| primary_topic.subfield.display_name | Molecular Biology |
| primary_topic.display_name | Ubiquitin and proteasome pathways |
| related_works | https://openalex.org/W2041171080, https://openalex.org/W1996655478, https://openalex.org/W2040045347, https://openalex.org/W2049961020, https://openalex.org/W2791495106, https://openalex.org/W2074680571, https://openalex.org/W2068643937, https://openalex.org/W3032979845, https://openalex.org/W3157017599, https://openalex.org/W1840165714 |
| cited_by_count | 51 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 8 |
| counts_by_year[1].year | 2024 |
| counts_by_year[1].cited_by_count | 8 |
| counts_by_year[2].year | 2023 |
| counts_by_year[2].cited_by_count | 13 |
| counts_by_year[3].year | 2022 |
| counts_by_year[3].cited_by_count | 11 |
| counts_by_year[4].year | 2021 |
| counts_by_year[4].cited_by_count | 10 |
| counts_by_year[5].year | 2020 |
| counts_by_year[5].cited_by_count | 1 |
| locations_count | 3 |
| best_oa_location.id | pmh:oai:pubmedcentral.nih.gov:7761918 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S2764455111 |
| best_oa_location.source.issn | |
| best_oa_location.source.type | repository |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | |
| best_oa_location.source.is_core | False |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | PubMed Central |
| best_oa_location.source.host_organization | https://openalex.org/I1299303238 |
| best_oa_location.source.host_organization_name | National Institutes of Health |
| best_oa_location.source.host_organization_lineage | https://openalex.org/I1299303238 |
| best_oa_location.license | |
| best_oa_location.pdf_url | |
| best_oa_location.version | submittedVersion |
| best_oa_location.raw_type | Text |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | False |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | Mol Cell |
| best_oa_location.landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/7761918 |
| primary_location.id | doi:10.1016/j.molcel.2020.10.008 |
| primary_location.is_oa | False |
| primary_location.source.id | https://openalex.org/S156208185 |
| primary_location.source.issn | 1097-2765, 1097-4164 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 1097-2765 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Molecular Cell |
| primary_location.source.host_organization | https://openalex.org/P4310320990 |
| primary_location.source.host_organization_name | Elsevier BV |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320990 |
| primary_location.license | |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Molecular Cell |
| primary_location.landing_page_url | https://doi.org/10.1016/j.molcel.2020.10.008 |
| publication_date | 2020-10-26 |
| publication_year | 2020 |
| referenced_works | https://openalex.org/W2134526812, https://openalex.org/W3007802993, https://openalex.org/W1982957001, https://openalex.org/W2799170276, https://openalex.org/W2169456326, https://openalex.org/W2252568502, https://openalex.org/W6639440402, https://openalex.org/W2510213801, https://openalex.org/W2949415937, https://openalex.org/W2097634547, https://openalex.org/W2117794327, https://openalex.org/W2338722087, https://openalex.org/W2798232370, https://openalex.org/W2053645860, https://openalex.org/W4240253200, https://openalex.org/W2165421630, https://openalex.org/W130887947, https://openalex.org/W2083459920, https://openalex.org/W2052113411, https://openalex.org/W2999051856, https://openalex.org/W2142031018, https://openalex.org/W2091207686, https://openalex.org/W2136277289, https://openalex.org/W2161171953, https://openalex.org/W2906377468, https://openalex.org/W2179438025, https://openalex.org/W2110844810, https://openalex.org/W1970209924, https://openalex.org/W2470708296, https://openalex.org/W2735132087, https://openalex.org/W2066324910, https://openalex.org/W2113684644, https://openalex.org/W2967738649, https://openalex.org/W2011923111, https://openalex.org/W2020679229, https://openalex.org/W2766300480, https://openalex.org/W2146512944, https://openalex.org/W2114104545, https://openalex.org/W1819171550, https://openalex.org/W2209936495, https://openalex.org/W1973260880, https://openalex.org/W2046691565, https://openalex.org/W2075766069, https://openalex.org/W2061197983, https://openalex.org/W2302002701, https://openalex.org/W2039827956, https://openalex.org/W2040860750, https://openalex.org/W2111403239, https://openalex.org/W1894583996, https://openalex.org/W2066893159 |
| referenced_works_count | 50 |
| abstract_inverted_index | |
| cited_by_percentile_year.max | 99 |
| cited_by_percentile_year.min | 89 |
| corresponding_author_ids | https://openalex.org/A5044648110 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 12 |
| corresponding_institution_ids | https://openalex.org/I4210117453 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.8299999833106995 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.92523979 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | True |